Stokes Family Office’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Stokes Family Office's EXAS Position: Q1 2026 in Review
Stokes Family Office sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,422 shares — an estimated $449K sold.
Stokes Family Office first reported a position in EXAS in Q4 2019 and held it in 22 quarters. The position peaked at $579K in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Stokes Family Office reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Stokes Family Office sold 4,422 Exact Sciences shares in Q1 2026, an estimated $449K.
- Stokes Family Office first reported a position in Exact Sciences in Q4 2019 and held it in 22 quarters.
- Stokes Family Office's Exact Sciences position peaked at $579K in Q4 2020.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.